A landmark study published today in Nature Genetics has identified 58 genetic variants linked to major anxiety disorders, offering the most comprehensive understanding to date of the biological roots of these common conditions. The research, conducted by an international team led by scientists at Texas A&M University, Dalhousie University, King’s College London and Würzburg JMU University, analyzed genetic data from a combined total of 1,953,222 individuals – 122,341 diagnosed with anxiety disorders and 729,881 serving as controls.
Anxiety disorders, encompassing generalized anxiety disorder, panic disorder, and phobias, affect an estimated one in four people at some point in their lives, often beginning in early adulthood and persisting for years. These conditions carry significant personal, social, and economic burdens. Despite their prevalence, the genetic underpinnings of anxiety have remained largely elusive, particularly when compared to other psychiatric illnesses.
“Anxiety disorders and their underlying sources of genetic risk have been understudied compared to other psychiatric conditions, so this study substantially advances this critical knowledge,” said Dr. Jack Hettema, professor from the Department of Psychiatry and Behavioral Sciences at the Texas A&M University Naresh K. Vashisht College of Medicine, and the study’s senior author. “Anxiety disorders have long been recognized as heritable, but until now we lacked a solid link between anxiety and the specific genetic factors involved.”
The study’s findings challenge the notion of a single “anxiety gene,” instead revealing a complex interplay of numerous genetic variants across the genome. Each variant contributes a slight degree of risk, collectively influencing an individual’s susceptibility to developing anxiety-related conditions. This genetic architecture mirrors that observed in common medical conditions like hypertension and depression, suggesting shared biological mechanisms.
Researchers also observed substantial genetic overlap between anxiety disorders and other related traits, including depression, neuroticism, post-traumatic stress disorder (PTSD), and suicidal ideation. Dr. Brad Verhulst, research assistant professor in the Department of Psychiatry and Behavioral Sciences at Texas A&M, explained, “Anxiety rarely occurs in isolation. Our findings help explain their frequent co-occurrence, underscoring the shared biology behind these forms of emotional distress.”
A key finding centers on the role of GABAergic signaling, a critical brain system responsible for regulating neuronal activity. GABA (gamma-aminobutyric acid) is a neurotransmitter that inhibits nerve cell activity, effectively calming the nervous system. Several existing anti-anxiety medications target this system, lending further support to its importance in anxiety disorders. “Our genomic findings provide converging evidence of the central role GABA plays for a part of the basis for clinical anxiety,” Hettema stated.
Although the study identifies genetic vulnerabilities, researchers emphasize that genes are not destiny. “Our discoveries highlight underlying biological vulnerability for anxiety, but they don’t diminish the profound influence of lived experience,” Verhulst cautioned. “Clarifying the influence of genetic factors that increase the risk of experiencing clinical anxiety may, in the future, help us to identify people who are particularly vulnerable. Our findings provide a starting point for developing early-intervention strategies and more effective, personalized treatments.”
The identified genetic variants and implicated pathways provide a roadmap for future research aimed at unraveling the molecular mechanisms underlying anxiety risk. Hettema noted that prioritizing genes for follow-up studies will allow scientists to explore how these genes influence brain function and contribute to the development of anxiety over time. The insights gained could potentially lead to improved diagnostic tools and targeted therapies.
However, Hettema stressed that the current findings do not support the use of genetic testing for diagnosing anxiety. “Identifying specific genes and biological pathways that contribute to mental health problems may help scientists better understand how anxiety develops,” he said, “and could inform the future development of modern treatments or the improvement of existing ones.”
